Sub analysis of Japanese patients with hemophilia B in rIX-FP clinical trial
Azusa Nagao(Ogikubo Hospital), Michio Sakai(Yao Tokushukai General Hospital), Midori Shima(Nara Medical University), Koji Yamamoto(Nagoya University Hospital), Tadashi Matsushita(Nagoya University Hospital), Hideji Hanabusa(Ogikubo Hospital), Keiji Nogami(Nara Medical University), Midori Kobayashi(FIND), Katsuyuki Fukutake(Tokyo Medical University), Yang JISIN(CSL (Switzerland)), Masashi Taki(St. Marianna University School of Medicine), Mitsuhiro Kuwahara(CSL (Switzerland)), Satoshi Higasa(Hyogo Medical University), Kagehiro Amano(Tokyo Medical University Hospital), Teruhisa Fujii(Hiroshima University Hospital)
Cited by 0
Related Papers
Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA.
|Proceedings of the National Academy of Sciences|1987|253
An antiangiogenic isoform of VEGF-A contributes to impaired vascularization in peripheral artery disease
|Nature Medicine|2014|197
Whole-body MRI for Detecting Metastatic Bone Tumor: Diagnostic Value of Diffusion-weighted Images
|Magnetic Resonance in Medical Sciences|2007|181
The × Gene of Hepatitis B Virus Induced Growth Stimulation and Tumorigenic Transformation of Mouse NIH3T3 Cells
|Japanese Journal of Cancer Research|1989|170
Molecular clock of silent substitution: At least six-fold preponderance of silent changes in mitochondrial genes over those in nuclear genes
|Journal of Molecular Evolution|1982|155